[Revival and adverse effects of heparin therapy: low molecular weight heparins; thrombogenic thrombopenias].
D000328:Adult; D000368:Aged; D001777:Blood Coagulation / Q000187:drug effects; D005260:Female; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D008970:Molecular Weight; D013329:Structure-Activity Relationship; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*; D013923:Thromboembolism / Q000097:blood / Q000139:chemically induced*
D006493:Heparin
Renouveau et rançon de l'héparinothérapie: les héparines de bas poids moléculaire; les thrombopénies thrombogéniques.